Porcine Carboxypeptidase B PMSF Treated
IPCCPDBPMSF1KUPorcine Carboxypeptidase B PMSF Treated from Innovative Research has been PMSF treated to inhibit tryptic and chymotryptic activities. This is a liquid with a concentration of >70 Units/mg protein.
This product catalyzes hydrolysis of the basic amino acids lysine, arginine and ornithine from the C-terminal end of polypeptides. Carboxypeptidase B is competitively inhibited by arginine, lysine and ornithine but not inhibited by di-isopropylfluorophosphate (DFP). It is inhibited by metal chelating agents such as 1,10-phenanthroline. Chymotrypsin and trypsin are less than 0.02%. One Unit hydrolyzes one micromole of hippuryl-L-arginine per minute at 25°C, pH 7.65. This is a solution in 100mM sodium chloride.
More Details:
- Source: Porcine Pancreas
- Storage Conditions: -20°C
At Innovative Research, we provide reliable, consistent products that deliver reliable, consistent results.
These products are supplied for manufacturing, research and laboratory use only. Researchers and laboratory personnel intending to use any of these products for medical investigation on humans are solely responsible for such use and for compliance with the pertinent regulations of the United States Food and Drug Administration (US-FDA) and other regulations. We do not assume liability for damages resulting from the handling, use and/or disposal of these products, from their use in violation of patent or other rights or reliance upon this information.
Please be aware the image pictured is for illustrative purposes only, and your product packaging and appearance may vary.
Get in touch with our team! Please include any relevant information (product name, etc)
